Quoin Pharmaceuticals, Ltd. (QNRX)
$4.24
-0.05 (-1.17%)
Rating:
Recommendation:
-
| Symbol | QNRX |
|---|---|
| Price | $4.24 |
| Beta | 0.000 |
| Volume Avg. | 0.16M |
| Market Cap | 4.186M |
| Shares () | - |
| 52 Week Range | 4.2-39.36 |
| 1y Target Est | - |
| DCF Unlevered | QNRX DCF -> | |
|---|---|---|
| DCF Levered | QNRX LDCF -> | |
| ROE | -111.70% | Strong Sell |
| ROA | -61.10% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | - | |
| P/E | 0.01 | Neutral |
| P/B | 0.04 | Neutral |
Latest QNRX news
About
Download (Excel)Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.